摘要:
The invention provides compositions and methods for treating diseases associated with expression of a cancer associated antigen as described herein. The invention also relates to chimeric antigen receptor (CAR) specific to a cancer associated antigen as described herein, vectors encoding the same, and recombinant T cells comprising the CARs of the present invention. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an antigen binding domain that binds to a cancer associated antigen as described herein.
摘要:
The invention provides anti-idiotypic fibronectin type III (Fn3) polypeptides that bind to an antibody of a target antigen using an antigen mimic sequence present in one or more loop regions. The anti-idiotypic Fn3 polypeptides of the invention can be used to generate or bind half-life extender molecules such as Human Serum Albumin (HSA), for improved half life and stability. The invention also provides methods for generating, screening and using the anti-idiotypic Fn3 polypeptides in a variety of therapeutic and diagnostic applications.
摘要:
The present invention relates to the field of protein display libraries and library screening, In preferred embodiments, the present invention provides a three component system for display comprising a cell surface molecule, an adapter molecule and a display molecule.
摘要:
A film scanner comprises a film support (3), driving means for moving a film (1 ) across said support (3) in a longitudinal direction, a photo-sensitive gate (5) for scanning images (2) of said film (1 ) placed on said support (3), a lateral abutment (9) and urging means (6, 15; 24, 25) for urging the film (1 ) against said abutment (9) in a transversal direction, characterized in that the abutment is formed by sprockets (9) of at least one sprocket wheel (8, 11 ) engaging perforation holes (4) of the film (1 ).
摘要:
A method and an arrangement for determining the position of a tape-like medium are proposed. The method provides for counting pulses which are supplied to the arrangement for determining the position to be counted, blocked or cancelled depending on the respective transport state. To this end, it is established whether the transport direction has been constant for a defined amount of time or over a defined distance. The transport direction determines whether the counter is incremented or decremented. In addition, counting pulses which rapidly follow one another are blocked in order to avoid undesirable double triggering. In order to avoid losing blocked counting pulses in an undesirable manner, the latter are stored and are applied to the counter, or discarded, depending on the transport state before and after blocking.
摘要:
Bei einem Verfahren zur Bildung eines Histogramms, das die Verteilung zugeführter Größen darstellt, die zugeführten Werten zugeordnet sind, welche innerhalb eines vorgegebenen Wertebereichs liegen, ist der Wertebereich in vorgegebene Teilbereiche aufgeteilt, die von Stützwerten begrenzt sind. Für Werte, die zwischen einem Stützwert und einem benachbarten Stützwert liegen, werden in Abhängigkeit von ihrer Lage Aufteilungsfaktoren berechnet. Die Größen werden in Abhängigkeit von den jeweiligen Aufteilungsfaktoren auf den jeweiligen Stützwert und den benachbarten Stützwert aufgeteilt und getrennt nach Stützwerten akkumuliert. Die akkumulierten Werte werden durch die Anzahl der jeweils getrennt nach Stützwerten akkumulierten Aufteilungsfaktoren dividiert.
摘要:
The invention provides compositions and methods for treating diseases associated with expression of a cancer associated antigen as described herein. The invention also relates to chimeric antigen receptor (CAR) specific to a cancer associated antigen as described herein, vectors encoding the same, and recombinant T cells comprising the CARs of the present invention. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an antigen binding domain that binds to a cancer associated antigen as described herein.
摘要:
The present invention provides gene editing systems comprising gene editing dimerization switches comprising a first and second gene editing switch domain that allow for the regulation of a gene editing function by the introduction, e.g., administration, of a gene editing dimerization molecule having the ability to bring together a first gene editing switch domain and a second gene editing switch domain. A regulated gene editing function provides, e.g., less off-target side effects, and increases the therapeutic window. The present invention also provides improved FKBP/FRB-based dimerization switches wherein the FRB switch domain or the FKBP switch domain, or both the FRB and FKBP switch domains, comprise one or more mutations that optimize performance, e.g., that alter, e.g., enhance the formation of a complex between the first switch domain, the second switch domain, and the dimerization molecule, rapamycin, or a rapalog, e.g., RAD001.
摘要:
The present invention provides compositions and methods for regulating the specificity and activity of immune effector cells for use in immunotherapy. In one embodiment, the invention provides a type of chimeric antigen receptor (CAR) wherein the CAR is termed a "NKR-CAR" which is a CAR design comprising a component of a receptor naturally found on natural killer (NK) cells. In one embodiment, the NK receptor includes but is not limited to a naturally occurring activating and inhibitory receptor of NK cells known as a killer cell immunoglobulin-like receptor (KIR).
摘要:
The invention provides compositions and methods for treating diseases associated with expression of EGFRvIII. The invention also relates to chimeric antigen receptor (CAR) specific to EGFRvIII, vectors encoding the same, and recombinant T cells comprising the anti- EGFRvIII CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an anti-EGFRvIII binding domain.